Sources: Google DeepMind spinout Isomorphic Labs is in talks to raise ~$5B at a ~$50B valuation; the AI drug discovery startup last raised $2.1B in May

BloombergNov 4, 4:15 PM PT

Context: The Alphabet-owned AI drug discovery company would raise roughly $5B at about a $50B valuation, after a $2.1B round in May.

From Bloomberg: Sources: Google DeepMind spinout Isomorphic Labs is in talks to raise ~$5B at a ~$50B valuation; the AI drug discovery startup last raised $2.1B in May — Alphabet Inc.'s Isomorphic Labs is in talks to raise roughly $5 billion in new funds to support its efforts to use artificial intelligence …

Isomorphic Labs · ~$5BAs stated by Bloomberg.

Source

Bloomberg (bloomberg.com)

Published

Nov 4, 4:15 PM PT

First seen here

Nov 4, 7:53 PM PT

Edition

Wednesday, November 4, 2026, ranked 5

Status

A publication reported this; the company may not have confirmed it.

Why it’s here

The largest AI round reported this week, at about a $50B valuation.

Topics

AI, Health